Jake worked with Jose Seoane in Christina Curtis’ lab to find that sensitively to TopoII inhibitors was determined by a chromatin accessibility network.  He also showed that members of this network including BAF predicted responses to TopoII inhibitor treatment in breast cancer.  In April 2021 Jake joined the faculty of the OMRF.